These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10341874)

  • 1. BP180 gene delivery in junctional epidermolysis bullosa.
    Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
    Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction.
    Zillikens D; Giudice GJ
    Arch Dermatol Res; 1999 Apr; 291(4):187-94. PubMed ID: 10335914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
    Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
    Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Herlitz junctional epidermolysis bullosa without hair involvement associated with BP180 deficiency.
    Guerriero C; De Simone C; Venier A; Rotoli M; Posteraro P; Zambruno G; Amerio P
    Dermatology; 2001; 202(1):58-62. PubMed ID: 11244233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.
    Bauer JW; Lanschuetzer C
    Clin Exp Dermatol; 2003 Jan; 28(1):53-60. PubMed ID: 12558632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BP180 (type XVII collagen) and its role in cutaneous biology and disease.
    Van den Bergh F; Giudice GJ
    Adv Dermatol; 2003; 19():37-71. PubMed ID: 14626817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.
    Pulkkinen L; Marinkovich MP; Tran HT; Lin L; Herron GS; Uitto J
    J Invest Dermatol; 1999 Dec; 113(6):1114-8. PubMed ID: 10636730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
    Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
    Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.
    Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E
    J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
    Fontao L; Tasanen K; Huber M; Hohl D; Koster J; Bruckner-Tuderman L; Sonnenberg A; Borradori L
    J Invest Dermatol; 2004 Jan; 122(1):65-72. PubMed ID: 14962091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
    Robbins PB; Lin Q; Goodnough JB; Tian H; Chen X; Khavari PA
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5193-8. PubMed ID: 11296269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
    Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain.
    Tasanen K; Floeth M; Schumann H; Bruckner-Tuderman L
    J Invest Dermatol; 2000 Aug; 115(2):207-12. PubMed ID: 10951237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
    Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
    J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Academy of Dermatology 1997 Awards for Young Investigators in Dermatology. Mutational analysis of the bullous pemphigoid antigen 2/type XVII collagen gene in patients with generalized atrophic benign epidermolysis bullosa.
    Darling TN
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):773-4. PubMed ID: 9366826
    [No Abstract]   [Full Text] [Related]  

  • 19. Autosomal dominant junctional epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
    Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
    Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.